Eslicarbazepine Acetate: A Double‐blind, Add‐on, Placebo‐controlled Exploratory Trial in Adult Patients with Partial‐onset Seizures

Abstract

Eslicarbazepine acetate was efficacious and well tolerated as an adjunctive therapy of refractory epileptic patients.